A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Can AI-Generated Molecules Be “Obvious” Under §103? Rethinking Nonobviousness in Algorithmic Chemistry
As artificial intelligence becomes an increasingly central tool in molecular design, a new question emerges for patent law: can a molecule generated by an AI system be deemed “obvious” under 35 U.S.C. §103? Traditional obviousness…
-
Who Is the Inventor When AI Designs a Molecule? A Legal Analysis of Conception in the Age of Machine Learning
Artificial intelligence is increasingly used to generate candidate drug molecules, proteins, and other biologically active compounds with minimal direct human design. In some cases, machine learning systems propose chemical structures or amino acid sequences that…
-
Methods and Composition for Treating CNS Disorders
Assignee: IGC Pharma, Inc.Patent Number: 12,465,589Filed: (Typical sequence begins earlier; patent granted Nov 11, 2025)Issued: November 11, 2025Title: Methods and Composition for Treating CNS Disorders What This Patent Covers This U.S. patent protects a proprietary…
BioTech IP Review 